Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder

OBJECTIVE: We examine weight gain and metabolic consequences of risperidone monotherapy in children with autism spectrum disorder (ASD). METHOD: This was a 24-week, multisite, randomized trial of risperidone only versus risperidone plus parent training in 124 children (mean age 6.9 ± 2.35 years; 105...

詳細記述

保存先:
書誌詳細
出版年:J Am Acad Child Adolesc Psychiatry
主要な著者: Scahill, Lawrence, Jeon, Sangchoon, Boorin, Susan J., McDougle, Christopher J., Aman, Michael G., Dziura, James, McCracken, James T., Caprio, Sonia, Arnold, L. Eugene, Nicol, Ginger, Deng, Yanhong, Challa, Saankari A., Vitiello, Benedetto
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4851735/
https://ncbi.nlm.nih.gov/pubmed/27126856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaac.2016.02.016
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料